Exact Mass: 433.1517

Exact Mass Matches: 433.1517

Found 148 metabolites which its exact mass value is equals to given mass value 433.1517, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

(2S)-2-[[4-[[(2R)-2-Amino-3-sulphanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulphanylbutanoic acid

C21H27N3O3S2 (433.1494)

2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid

2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(morpholin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid

C22H22F3N3O3 (433.1613)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents

1-(2-Methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline

1-(4-Methoxy-2-methylphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline

C22H22F3N3O3 (433.1613)

D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors

N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide

N-[(1-{[2-(diethylamino)ethyl]amino}-9-oxo-9H-thioxanthen-4-yl)methyl]methanesulphonamide

C21H27N3O3S2 (433.1494)

MMV676571

C24H20FN3O4 (433.1438)

Nitrile,1-O-beta-rutinoside-glucopyranoside,penta-Ac-1,4-Dihydroxy-2-cyclopentene-1-carboxylic acid

C18H27NO11 (433.1584)

Ala Asn Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)

His Tyr Asp

C19H23N5O7 (433.1597)

Asp His Tyr

C19H23N5O7 (433.1597)

Tyr Asp His

C19H23N5O7 (433.1597)

His Asp Tyr

C19H23N5O7 (433.1597)

12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one

C25H23NO6 (433.1525)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.276 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.275 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.279

MMV676571

C24H20N3O4F (433.1438)

Ala Asp Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)

Ala Asp Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asp Ala Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)

Asp Ala Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asp Asp Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]propanamido]-3-carbamoylpropanoic acid

C15H23N5O10 (433.1445)

Asp Asp Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]acetamido}-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)

Asp Asp Asn Ala

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)

Asp Asp Gln Gly

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)

Asp Glu Gly Asn

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)

Asp Glu Asn Gly

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Asp Gly Asp Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)

Asp Gly Glu Asn

(4S)-4-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Asp Gly Gly Trp

(3S)-3-amino-3-({[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]methyl}carbamoyl)propanoic acid

C19H23N5O7 (433.1597)

Asp Gly Asn Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carbamoylpropanamido]pentanedioic acid

C15H23N5O10 (433.1445)

Asp Gly Gln Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-carbamoylbutanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asp Gly Trp Gly

(3S)-3-amino-3-[({[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)

Asp Asn Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]propanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asp Asn Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)

Asp Asn Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)

Asp Asn Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]acetamido}pentanedioic acid

C15H23N5O10 (433.1445)

Asp Gln Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O10 (433.1445)

Asp Gln Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)

Asp Trp Gly Gly

(3S)-3-amino-3-{[(1S)-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)

Glu Asp Gly Asn

(4S)-4-amino-4-{[(1S)-1-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Glu Asp Asn Gly

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Glu Gly Asp Asn

(4S)-4-amino-4-[({[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)

Glu Gly Asn Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Glu Asn Asp Gly

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Glu Asn Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)

Gly Asp Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C15H23N5O10 (433.1445)

Gly Asp Glu Asn

(4S)-4-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Gly Asp Gly Trp

(3S)-3-(2-aminoacetamido)-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)

Gly Asp Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carbamoylpropanamido]pentanedioic acid

C15H23N5O10 (433.1445)

Gly Asp Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-carbamoylbutanamido]butanedioic acid

C15H23N5O10 (433.1445)

Gly Asp Trp Gly

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)

Gly Glu Asp Asn

(4S)-4-(2-aminoacetamido)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Gly Glu Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-3-carbamoylpropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Gly Gly Asp Trp

(3S)-3-[2-(2-aminoacetamido)acetamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)

Gly Gly Trp Asp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C19H23N5O7 (433.1597)

Gly Asn Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carboxypropanamido]pentanedioic acid

C15H23N5O10 (433.1445)

Gly Asn Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carboxybutanamido]butanedioic acid

C15H23N5O10 (433.1445)

Gly Gln Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Gly Trp Asp Gly

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)

Gly Trp Gly Asp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C19H23N5O7 (433.1597)

Trp Asn Asp

C19H23N5O7 (433.1597)

Asp Trp Asn

C19H23N5O7 (433.1597)

Asp Asn Trp

C19H23N5O7 (433.1597)

Asn Ala Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asn Asp Ala Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]propanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asn Asp Asp Ala

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O10 (433.1445)

Asn Asp Glu Gly

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H23N5O10 (433.1445)

Asn Asp Gly Glu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]acetamido}pentanedioic acid

C15H23N5O10 (433.1445)

Asn Glu Asp Gly

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}butanoic acid

C15H23N5O10 (433.1445)

Asn Glu Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)

Asn Gly Asp Glu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carboxypropanamido]pentanedioic acid

C15H23N5O10 (433.1445)

Asn Gly Glu Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carboxybutanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asn Asp Trp

C19H23N5O7 (433.1597)

Gln Asp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O10 (433.1445)

Gln Asp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]acetamido}butanedioic acid

C15H23N5O10 (433.1445)

Gln Gly Asp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carboxypropanamido]butanedioic acid

C15H23N5O10 (433.1445)

Asn Trp Asp

C19H23N5O7 (433.1597)

Trp Asp Gly Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid

C19H23N5O7 (433.1597)

Trp Gly Asp Gly

(3S)-3-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)

Trp Gly Gly Asp

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)butanedioic acid

C19H23N5O7 (433.1597)

4-BROMO-N-DODECYL-1-HYDROXY-2-NAPHTHALENECARBOXAMIDE

C23H32BrNO2 (433.1616)

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide

C21H21F2N3O5 (433.1449)

Fmoc-N(Hmb)-Gly-OH

C25H23NO6 (433.1525)

4-Aminophenyl-beta-D-lactopyranoside

C18H27NO11 (433.1584)

2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate

C22H27ClN2O3P++ (433.1448)

9-AMino-(9-deoxy)epi-dihydroquinine trihydrochloride

C20H30Cl3N3O (433.1454)

p-Aminophenyl-beta-D-cellobioside

C18H27NO11 (433.1584)

Hydroxychloroquine sulfate

C18H28ClN3O5S (433.1438)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide

C21H27N3O3S2 (433.1494)

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

C21H27N3O3S2 (433.1494)

N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide

C22H20ClN7O (433.1418)

Tcmdc-142582

C24H20FN3O4 (433.1438)

(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid

(2S)-2-[[4-[[(2R)-2-Amino-3-sulphanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulphanylbutanoic acid

C21H27N3O3S2 (433.1494)

N-{4-[(1H-benzotriazol-1-ylacetyl)(thiophen-3-ylmethyl)amino]phenyl}-2-methylpropanamide

C23H23N5O2S (433.1572)

2-[[7-(4-Methoxyphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]thio]propanoic acid ethyl ester

C24H23N3O3S (433.146)

[1-[1-[4-(difluoromethoxy)phenyl]-2,5-dimethylpyrrol-3-yl]-1-oxopropan-2-yl] 6-oxo-4,5-dihydro-1H-pyridazine-3-carboxylate

C21H21F2N3O5 (433.1449)

1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea

C24H23N3O3S (433.146)

Asp-Trp-Asn

C19H23N5O7 (433.1597)

Trp-Asn-Asp

C19H23N5O7 (433.1597)

Tyr-His-Asp

C19H23N5O7 (433.1597)

N-(2,5-dimethoxyphenyl)sulfonyl-N-(4-methoxyphenyl)cyclohexanecarboxamide

C22H27NO6S (433.1559)

N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)

(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)

[(2S,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)

[(2S,3S)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)

N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)

N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)

(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)

(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)

[(2R,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)

Penotonium bromide

C23H32BrNO2 (433.1616)

Asn-Asp-Trp

C19H23N5O7 (433.1597)

Trp-Asp-Asn

C19H23N5O7 (433.1597)

Asn-Trp-Asp

C19H23N5O7 (433.1597)

Asp-Asn-Trp

C19H23N5O7 (433.1597)

Asp-His-Tyr

C19H23N5O7 (433.1597)

Asp-Tyr-His

C19H23N5O7 (433.1597)

His-Asp-Tyr

C19H23N5O7 (433.1597)

His-Tyr-Asp

C19H23N5O7 (433.1597)

Tyr-Asp-His

C19H23N5O7 (433.1597)

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione

C25H23NO6 (433.1525)

G907

C26H24ClNO3 (433.1445)

G907 is a selective antagonist of ATP-binding cassette (ABC) transporter MsbA with anti-microbial activity. G907 inhibits E. coli MsbA with an IC50 value of 18 nM. G907 traps MsbA in an inward-facing, lipopolysaccharide-bound conformation by wedging into an architecturally conserved transmembrane pocket[1][2].

PHT-7.3

C24H23N3O3S (433.146)

PHT-7.3 is a selective inhibitor of connector enhancer of kinase suppressor of Ras 1 (Cnk1) pleckstrin homology (PH) domain (Kd=4.7 μM). PHT-7.3 inhibits mut-KRas, but not wild-type KRas cancer cell and tumor growth and signaling. PHT-7.3 has antitumor activity[1].

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

(2e)-n-[2-(4-{[(2e)-3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

C22H27NO6S (433.1559)

1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxycyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

n-[2-(4-{[3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

C22H27NO6S (433.1559)

4-hydroxy-1-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

4-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

(1s,4r)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)

4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)